| Ytd | 22.71% | |
| 1y | 52.51% |
| Open | 25.33 | Prev Close | 26.61 | Low | 25.76 | High | 26.54 | Mkt Cap | 2.13B |
| Vol | 256.96K | Avg Vol | 798.34K | EPS | 2.09 | P/E | 12.55 | Forward P/E | 10.92 |
| Beta | 0.66 | Short Ratio | 6.06 | Inst. Own | 107.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 26.00 | 200-d Avg | 22.88 | 1yr Est | 26.33 |
Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagi
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and pri
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and r
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its gr
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results desp
Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and rea
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.63 per share, beating the Zacks
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the anal
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Resul
Allspring Global Investments Holdings LLC increased its holdings in Pediatrix Medical Group, Inc. (N
Shares of Pediatrix Medical Group, Inc. (NYSE: MD - Get Free Report) have received a consensus recom
Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading pr
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group, Inc. (NYSE: MD) (“Pediatrix
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
One of the biggest mistakes investors make is spending all their time looking for what is cheap and
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
JACKSONVILLE BEACH, Fla.--(BUSINESS WIRE)--MedAxiom, the premier source for cardiovascular organizat
OWINGS MILLS, MD, June 22, 2026 (GLOBE NEWSWIRE) -- The National Capital Chesapeake Bay Chapter of t
George Hill, Anguilla, 17 June 2026 -- As competition for medical school places in the United Kingdo
Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the p
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.50 per share which missed the an
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the anal
Leerink Partners analyst Whit Mayo maintains Pediatrix Medical Group (NYSE:MD) with a Market Perf
Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced t
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p